Apolipoprotein e alleles in cuban patients with mild cognitive impairment

N/ACitations
Citations of this article
53Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Apolipoprotein E (ApoE) ε4 genotype is the most clearly documented risk factor for Alzheimers disease (AD). Epidemiological studies demonstrate an accelerated rate of progression to dementia and AD in patients with mild cognitive impairment (MCI). We assessed the ApoE allele and genotypes frequencies in Cuban patients with MCI. Methods: We performed ApoE genotyping of 74 Cuban patients more than 65 years old. Cognitive assessments included the Mini-Mental State Examination (MMSE) and a cognitive battery for evaluating memory, attention, perception, and executive function. Results: Cognitive impairments were characterized by amnesia and executive deficits in patients with MCI. The Apo ε4 allele frequency was 0.196 in patients with MCI, 10-fold higher than that in the controls. Patients carrying the ε4 allele exhibited poorer performance in MMSE and tests assessing executive function and short-term memory than noncarriers. Conclusions: The patients exhibited amnestic MCI multiple domains. Cognitive performance was worse in patients who carried the ApoE e4 allele. © The Author(s) 2013.

Cite

CITATION STYLE

APA

Suárez, V. M., Fernández, Y., López, E. D. C. R., Clarke, D. H., Bobes, M. A., Riverón, A. M., & López-Cánovas, L. (2014). Apolipoprotein e alleles in cuban patients with mild cognitive impairment. American Journal of Alzheimer’s Disease and Other Dementias, 29(3), 236–241. https://doi.org/10.1177/1533317513517037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free